Enhanced bioprocess control to advance the manufacture of mesenchymal stromal cell‐derived extracellular vesicles in stirred‐tank bioreactors
Open Access
- 8 June 2023
- journal article
- research article
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 120 (9) , 2725-2741
Abstract
Extracellular vesicles (EVs) derived from mesenchymal stromal cells (MSCs) act as signaling mediators of cellular responses. However, despite representing a promising alternative to cell‐based therapies, clinical translation of EVs is currently limited by their lack of scalability and standardized bioprocessing. Herein, we integrated scalable downstream processing protocols with standardized expansion of large numbers of viable cells in stirred‐tank bioreactors to improve EV production. Higher EV yields were linked to EV isolation by tangential flow filtration followed by size exclusion chromatography, rendering 5 times higher number of EVs comparatively to density gradient ultracentrifugation protocols. Additionally, when compared to static culture, EV manufacture in bioreactors resulted in 2.2 higher yields. Highlighting the role of operating under optimal cell culture conditions to maximize the number of EVs secreted per cell, MSCs cultured at lower glucose concentration favored EV secretion. While offline measurements of metabolites concentration can be performed, in this work, Raman spectroscopy was also applied to continuously track glucose levels in stirred‐tank bioreactors, contributing to streamline the selection of optimal EV collection timepoints. Importantly, MSC‐derived EVs retained their quality attributes and were able to stimulate angiogenesis in vitro, therefore highlighting their promising therapeutic potential.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia
This publication has 57 references indexed in Scilit:
- Exploring continuous and integrated strategies for the up- and downstream processing of human mesenchymal stem cellsJournal of Biotechnology, 2015
- Exosomes derived from alcohol-treated hepatocytes horizontally transfer liver specific miRNA-122 and sensitize monocytes to LPSScientific Reports, 2015
- MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host diseaseLeukemia, 2014
- The impact of disparate isolation methods for extracellular vesicles on downstream RNA profilingJournal of Extracellular Vesicles, 2014
- Serum‐free media for the production of human mesenchymal stromal cells: a reviewCell Proliferation, 2013
- Exosomal Signaling during Hypoxia Mediates Microvascular Endothelial Cell Migration and VasculogenesisPLOS ONE, 2013
- miRNAs as Modulators of AngiogenesisCold Spring Harbor Perspectives in Medicine, 2012
- Hypoxic enhancement of exosome release by breast cancer cellsBMC Cancer, 2012
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006